We have located links that may give you full text access.
Journal Article
Review
Diagnosis of prostatic carcinoma after therapy.
Archives of Pathology & Laboratory Medicine 2007 March
CONTEXT: Prostate cancer is the most common cancer of men in the United States and is third only to lung and colon cancer as a cause of cancer death. In 2006, 27,350 Americans will die of prostate cancer, and 234,460 new cases will be diagnosed. Treatment changes in the benign and cancerous prostate create diagnostic challenges in pathologic interpretation, particularly in needle biopsy specimens and in evaluation of extraprostatic metastases.
OBJECTIVE: To summarize therapy-related pathologic findings in the prostate with emphasis on recognition of treated adenocarcinoma.
DATA SOURCES: Extensive review of published literature and the authors' experience.
CONCLUSIONS: Following therapy for prostate cancer, it is critical that the clinician provide the pertinent history of androgen deprivation or radiation therapy to assist the pathologist in rendering the correct diagnosis.
OBJECTIVE: To summarize therapy-related pathologic findings in the prostate with emphasis on recognition of treated adenocarcinoma.
DATA SOURCES: Extensive review of published literature and the authors' experience.
CONCLUSIONS: Following therapy for prostate cancer, it is critical that the clinician provide the pertinent history of androgen deprivation or radiation therapy to assist the pathologist in rendering the correct diagnosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app